Rezolve AI (REZV) Plunges 8.33% as Profit-Taking and Valuation Gaps Fuel Sell-Off

Rezolve AI fell 8.33% in pre-market trading on Nov. 14, 2025, marking its largest single-day decline in over a year amid heightened market volatility and sector-wide profit-taking pressures.

The sharp selloff follows a recent surge in speculative activity around AI-driven healthcare tools, with analysts noting valuation gaps between Rezolve's revenue growth and its peer group. Short-interest data from Wednesday showed a 12% increase in open short positions, suggesting bearish positioning ahead of its Q3 earnings report scheduled for Nov. 21.

Technical indicators reinforce near-term bearish momentum, with the stock breaching key support at $4.15 and testing its 50-day moving average. Options market activity reveals a 35% rise in put options traded this week, reflecting investor caution around regulatory scrutiny of AI healthcare applications in the EU.

Backtest assumptions suggest a mean-reversion strategy triggered at $4.00 with 15% stop-loss could have captured 22% of intraday volatility between July and October 2025. However, current positioning metrics indicate extended short-term downside risk, with the 200-day moving average now acting as a critical psychological barrier at $3.80.